Introduction
Spirometry can indicate various lung diseases and help determine their treatment and prognosis. 1 The role of spirometry values, including forced expiratory volume in 1 second (FEV 1 ) and the ratio of FEV 1 to forced vital capacity (FEV 1 /FVC), is well established in the diagnosis, the classification of disease severity, and the prediction of mortality for patients with COPD. 2 However, the method used to define the cut-off value of airflow limitation for the diagnosis of COPD has been debated by two groups. One group suggested that the cut-off value of airflow limitation be defined by a fixed ratio (FEV 1 /FVC ,0.70 or/and FEV 1 ,80% of predicted value), 3 while the other group suggested that the cut-off value of airflow limitation by the lower limit of normal (FEV 1 /FVC or/and FEV 1 less than the bottom 5% percentile of normal reference value) which has the same meaning as "the Z-score of FEV 1 /FVC or/and FEV 1 ,-1.64". 4 In addition to both of these suggestions, there is a third method used to define the cut-off value of airflow limitation, a spirometry T-score. Similar to defining the T-score of bone mineral density, spirometry T-score can be defined by the spirometry values corrected with the young age where the lung function is at peak. Older subjects are more vulnerable to, and have poorer outcomes due to respiratory diseases even though they may have the same spirometry values that are expressed in spirometry Z-score. 5, 6 In the present study, we hypothesized that spirometry T-score may better predict the four outcomes of all-cause death, respiratory death, COPD death, and COPDrelated health care utilization (COPD utilization) .
In this study, we developed the spirometry T-score. In addition, we compared the three methods of the fixed ratio, the spirometry Z-score, and T-score to answer the question as to which method has the best prediction performance for the four outcomes.
Methods Overview
We performed this study using representative samples of the two general populations, the US and Korean. In relation to the spirometry values, the three outcomes of all-cause death, respiratory death, and COPD death were evaluated in 9,101 subjects followed for 10 years in the Third National Health and Nutrition Examination Survey (US NHANES III). The fourth outcome of COPD utilization was evaluated in 1,894 subjects followed for 4 years in the Second Korean National Health and Nutritional Examination Survey (Korean NHANES II).
Calculation of spirometry Z-scores and T-scores
We developed the spirometry T-score by analogy to the bone mineral density T-score, which is expressed in standard deviation units relative to a reference in a young, normal population. 7 However, in addition to age, spirometry values are also dependent on height. Therefore, taking into consideration age and height for the development of a spirometry T-score, we used the lambda-mu-sigma (LMS) method, where spirometry values of median (mu), coefficient of variation (sigma), and skewness (lambda) were modeled. 8 For the 9,101 US subjects, we calculated spirometry Z-scores and T-scores using look-up tables using a Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) add-in the module, which has been developed by Stanojevic et al. 9, 10 The young, normal reference for FEV 1 and the FEV 1 /FVC ratio in the US population was the value at 23 years of age in males and 22 years of age in females, which are the ages when the median FEV 1 is the highest.
As for the 1,894 Korean subjects, we calculated spirometry Z-scores and T-scores using Korean reference equations developed with the LMS method (Table S1 ). The age of the young, normal reference for FEV 1 and the FEV 1 /FVC ratio, was 19 years in males and 32 years in females for Koreans.
Us nhanes III data
We used anonymous, publically available data of 9,101 subjects from the US NHANES III, which is a large, representative, stratified, random survey of the US population from 8 to 80 years of age. 11 For this study, we used only the data of non-Hispanic white participants 17-80 years of age, who completed at least three acceptable spirometry maneuvers and also whose mortality status and height were available ( Figure S1 ). The spirometry methods used in the US NHANES III have been described previously by Hankinson et al 11 and in Centers for Disease Control and Prevention. 12 all-cause death, respiratory death, and COPD death after 10 years of follow-up
The US NHANES III recorded all-cause deaths, which were ascertained from a public-use-linked mortality file that contains information based on the National Death Index. Deaths from a respiratory cause were defined by the International Classification of Diseases (ICD) J10-J98 codes; deaths from COPD were defined the ICD codes of J40-J47 (but not including the asthma codes J45 or J46).
survival curves and hazard ratios of spirometry T-scores
The Kaplan-Meier survival curves for the groups stratified by their spirometry T-scores were calculated with the log-rank test. The stratification of groups for the Kaplan-Meier curves was determined arbitrarily, but the first level of cut-off was determined with FEV 1 T-score of -2.5, below which the probability of all-cause death appeared to increase steeply ( Figure 1 ). Hazard ratios of the spirometry T-score for death was calculated by Cox proportional hazard analysis with adjustment for age, sex, smoking history, and co-morbidity, including cancer, heart attack, heart failure, and diabetes.
COPD utilization during 4 years of follow-up
We linked the data of 1,894 subjects that were 40 years of age or older of the Korean NHANES II with the Korean National Health Insurance claims ( Figure S2 ). 13 In this study, we considered that health care utilization related to COPD occurred if a participant in KHANES II in 2001 used health care services including any procedures, tests, or treatments with a primary diagnosis of COPD between 2002 and 2005 based on data from Korean National Health Insurance claims.
statistical analyses
Statistical analyses were performed using SPSS software, version 18.0 (SPSS Inc., Chicago, IL, USA) and SAS 9.2 (SAS Institute Inc., Cary, NC, USA). In addition, pROC in the R 2. 
Results
results from the analyses of the Us nhanes III subject characteristics of the Us nhanes III Among the 9,101 subjects, 51% were female. The mean age was 45 years and 52% had a smoking history (Table 1) . Death from any cause occurred in 929 (10.2%) subjects during the 10 years of follow-up. Eighty-five subjects (0.9%) died of respiratory causes; 43 deaths (0.5%) were caused by COPD.
spirometry T-score for the prediction of all-cause death, respiratory, and COPD death
The probability of all-cause death, respiratory death, and COPD death during 10 years of follow-up appeared to increase steeply as FEV 1 T-score decreased to negative values ( Figure 1 ). The probability of all-cause death appeared to remain zero or nearly zero until an FEV 1 T-score of approximately -1, and this increased slowly until reaching a score of approximately -2.5, after which the probability of death appeared to increase steeply ( Figure 1A ).
For the prediction of all-cause, respiratory, and COPD death, the prediction performance of the FEV 1 T-score was higher than that of the FEV 1 Z-score or the FEV 1 percent of predicted value (P,0.001 for all comparisons; Figure 2A -C). As for the T-score of FEV 1 /FVC, the prediction performance was lower than FEV 1 T-score (P,0.05 for all comparisons; Figure 2A -C and E-G).
The prediction performance of FEV 1 /FVC ratio itself was comparable to that of FEV 1 /FVC T-score for the prediction of respiratory death and COPD death (P=0.93 and 0.68, respectively; Figure 2F and G), and was even higher than that of FEV 1 /FVC T-score for the prediction of all-cause death (P,0.001 for both comparisons; Figure 2E ). The prediction performance of the FEV 1 /FVC ratio was higher than that of FEV 1 /FVC Z-score for the prediction of all-cause death, respiratory death, COPD death, and COPD utilization (P,0.0001 for all comparisons; Figure 2E -G).
Cut-off values of spirometry T-scores for the prediction of all-cause death
The cut-off values of the FEV 1 T-score that reached the maximum Youden index (sensitivity + specificity -1) for the prediction of all-cause death were -2.5 in males and -2.4 in females. The corresponding FEV 1 /FVC T-scores were -1.1 in males and -1.6 in females. For the prediction of 10-year all-cause death, an FEV 1 T-score of -2.5 had a sensitivity 
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spirometry T-score 78 and a specificity of 0.78, which were higher than the indices calculated using the other criteria of abnormal spirometry ( Table 2) . For the prediction of COPD death, the FEV 1 /FVC ratio with the cut-off value of 0.70 appeared to be comparable to FEV 1 T-score with the cut-off value of -2.5 ( Table 2) .
survival curves and hazard ratios of the FeV 1 T-score Survival curves for all-cause death, respiratory death, and COPD death differed significantly among the groups when stratified into four groups (,-4.5, -4.5 to -3.6, -3.5 to -2.6, and $-2.5) by FEV 1 T-score (P,0.001 for all log-rank tests; Figure 3A -C).
The adjusted hazard ratios of the FEV 1 T-score for all-cause death, respiratory death, and COPD death were 0.54 (95% CI: 0.48-0.60), 0.43 (95% CI: 0.37-0.50), and 0.30 (95% CI: 0.24-0.37), respectively, adjusting for age, sex, smoking history, and co-morbidity in the US subjects (P,0.0001 for all Cox proportional hazard analyses).
results from the analyses of the Korean nhanes II subject characteristics Among 1,894 subjects from the Korean NHANES II data, 51% were female. The mean age was 53 years, and 40% had a smoking history (Table 1) . COPD utilization was observed for 156 (8.2%) subjects during 4 years of follow-up.
spirometry T-score for the prediction of COPD utilization
The probability of COPD utilization during 4 years of follow-up increased steeply as FEV 1 T-score decreased to negative values ( Figure 1I ).
For the prediction of COPD utilization, the prediction performance of the FEV 1 T-score was higher than that of the FEV 1 Z-score or the FEV 1 percent of predicted value (P,0.05 for both comparisons; Figure 2D ). As for the ratio of FEV 1 / FVC, the prediction performance was higher than that of FEV 1 /FVC T-score or Z-score for the prediction of COPD utilization (P,0.05 for both comparisons; Figure 2H ).
As for the prediction of COPD utilization, the cut-off value of FEV 1 T-score was -1.5 and this reached the maximum of Youden index (Table S2 ).
survival curves and hazard ratios of the FeV 1 T-score
Survival curves for COPD utilization differed significantly among the groups when stratified by FEV 1 T-score (P,0.001 Table 2 Various criteria of abnormal spirometry for the prediction of all-cause death, respiratory death, COPD death, and COPD-related health care utilization 
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spirometry T-score for log-rank test; Figure 3D ). The adjusted hazard ratio of the FEV 1 T-score for COPD utilization was 0.69 (95% CI: 0.59-0.81) adjusting for age, sex, amount smoked, monthly income, presence of pulmonary symptoms, and physician-diagnosed COPD in the Korean subjects (P,0.001; Cox proportional hazard analysis).
Discussion
In this study, we developed a spirometry T-score that could predict all-cause death, respiratory death, and COPD death in the US population and COPD utilization in the Korean population. This study suggests that spirometry values might also be corrected in the same way as that of the diagnosis of osteoporosis for which a young, normal reference is used to determine T-scores of bone mineral density. The rationale for using T-score might be that the age-related vulnerability should be taken into account; 5,6 the rationale for Z-scores is that the age-related variability should be taken into account.
We found that the probability of all-cause death appeared to increase steeply when the FEV 1 T-score decreased below approximately -2.5 ( Figure 1A) . We also found that the optimal cut-off values of the FEV 1 T-score for the prediction of all-cause death were -2.5 in males and -2.4 in females, where the Youden index reached the maximum value. However, which cut-off value of spirometry should be chosen might be dependent on the outcome. As for the outcome of COPD utilization, the cut-off value of -1.5 in FEV 1 T-score was the value where Youden index was the maximum (Table S2 ).
We also found that the prediction performance of FEV 1 / FVC ratio itself was comparable to, or even better than that of FEV 1 /FVC T-score, for the prediction of all-cause death, respiratory death, COPD death, and COPD utilization (Figure 2E−H) . In addition, the criteria of abnormal spirometry by "FEV 1 /FVC ,0.70" were comparable to that by "FEV 1 T-score ,-2.5" for the prediction of COPD death ( Table 2 ). However, the prediction performance of FEV 1 /FVC Z-score did not appear to be as good as that of FEV 1 /FVC ratio itself or T-score. The prediction performance for COPD death had a sensitivity of 0.63 and a specificity of 0.93, with a Youden index of 0.56 given that the criterion of abnormal spirometry was an FEV 1 /FVC ratio less than the lower limit of normal, bottom 5% percentile (which has the same meaning as an FEV 1 /FVC Z-score less than -1.64) ( Table 2 ). If the criterion FEV 1 /FVC ,0.70 was chosen, then the sensitivity would be 0.79 and specificity 0.85, with a Youden index of 0.64. These results might support the definition of airflow limitation using the FEV 1 /FVC criterion of less than 0.70, suggested by the COPD clinical practice guidelines. 14, 15 The T-score of bone mineral density is known to reflect future fracture risk. A recent meta-analysis found that fracture risk increases by 1.5-fold to 2.6-fold for every unit decrease in standard deviation of mean bone mineral density. 16 In our study, one standard deviation decrease in FEV 1 T-score increased the risk of all-cause death by 1.9 times (the reciprocal of 0.54), respiratory death by 2.3 times (1/0.43), COPD death by 3.3 times (1/0.30), and COPD-related health care utilization by 1.4 times (1/0.69). Therefore, FEV 1 T-scores might be comparable to T-scores of bone mineral density.
There are some limitations to discuss. First, determining cause of death is not easy or clear, so ICD disease coding might not be as accurate as assumed in this study. However, the large sample size of this study would probably overcome a coding issue. In addition, ICD disease coding has already been validated in previous studies in both US and Korean subjects. 13, 17 Second, to apply these study results to COPD patients, post-bronchodilator spirometry may be needed, because the clinical practice guidelines of COPD management suggest post-bronchodilator spirometry for the diagnosis and classification of COPD. Unfortunately, post-bronchodilator spirometry data are not available for the general population in the US or in Korea. The importance of post-bronchodilator spirometry may be challenged, because the clinical significance of bronchodilator responsiveness is not universally accepted. 18 Third, this study included only white US and Korean participants and therefore, general application to other ethnicities can be limited. For subjects of other ethnicities, a global lung function equation developed by Quanjer et al 19 may be of assistance. Finally, although Youden index is used to determine which methods are superior to others, it is not always informative. The usefulness of Youden index, also the sensitivity and specificity, are mainly determined on the setting or the goal. For example, the FEV/FVC ratio below the LLN would be better than the fixed FEV/FVC ratio in a situation where a physician would be in the clinical context of selecting patients who are not at risk of COPD.
Compared with the conventional diagnostic criteria of COPD, FEV 1 T-score appears to be superior in prediction performance of important outcomes. Therefore, with the superior prediction performance of spirometry T-score, should we use it in clinical practice? Without a consensus of experts or academic societies, we should be prudent to use it in clinical practice, because a vast majority of evidences have been built with the diagnostic criteria of FEV 1 /FVC with a cut-off of 0.70 in research of COPD. Because this study shows that the criteria FEV 1 /FVC of less than 0.70 works acceptably and because spirometry T-score seems to be too complicated to develop, we suggest that the conventional diagnostic criteria of FEV 1 /FVC, with a cut off of 0.70, be acceptable for the diagnosis of COPD in clinical practice.
Conclusion
Spirometry T-score with the age of young, normal reference could predict all-cause death, respiratory death, COPD death, and COPD utilization.
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